Works matching IS 15747891 AND DT 2022 AND VI 16 AND IP 13

Results: 9

Corrigendum to: iRGD-modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation.
Published in:
Molecular Oncology, 2022, v. 16, n. 13, p. 2607, doi. 10.1002/1878-0261.13258
Publication type:
Article
DRP1 contributes to head and neck cancer progression and induces glycolysis through modulated FOXM1/MMP12 axis.
Published in:
Molecular Oncology, 2022, v. 16, n. 13, p. 2585, doi. 10.1002/1878-0261.13212
By:
- Tai-Lin Huang;
- Chuang-Rung Chang;
- Chih-Yen Chien;
- Gong-Kai Huang;
- Yi-Fan Chen;
- Li-Jen Su;
- Hsin-Ting Tsai;
- Yu-Sheng Lin;
- Fu-Min Fang;
- Chang-Han Chen
Publication type:
Article
SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK.
Published in:
Molecular Oncology, 2022, v. 16, n. 13, p. 2558, doi. 10.1002/1878-0261.13208
By:
- Xiu Shi;
- Xuejiao Yu;
- Juan Wang;
- Shimin Bian;
- Qiutong Li;
- Fengqing Fu;
- Xinwei Zou;
- Lin Zhang;
- Bast Jr., Robert C.;
- Zhen Lu;
- Lingchuan Guo;
- Youguo Chen;
- Jinhua Zhou
Publication type:
Article
Precision medicine-based therapies in advanced colorectal cancer: The University of California San Diego Molecular Tumor Board experience.
Published in:
Molecular Oncology, 2022, v. 16, n. 13, p. 2575, doi. 10.1002/1878-0261.13202
By:
- Louie, Bryan H.;
- Shumei Kato;
- Ki Hwan Kim;
- Hyo Jeong Lim;
- Lee, Suzanna;
- Ryosuke Okamura;
- Fanta, Paul T.;
- Kurzrock, Razelle
Publication type:
Article
FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma.
Published in:
Molecular Oncology, 2022, v. 16, n. 13, p. 2470, doi. 10.1002/1878-0261.13195
By:
- Lindén, Malin;
- Vannas, Christoffer;
- Österlund, Tobias;
- Andersson, Lisa;
- Osman, Ayman;
- Escobar, Mandy;
- Fagman, Henrik;
- Ståhlberg, Anders;
- Åman, Pierre
Publication type:
Article
TLK1-mediated MK5-S354 phosphorylation drives prostate cancer cell motility and may signify distinct pathologies.
Published in:
Molecular Oncology, 2022, v. 16, n. 13, p. 2537, doi. 10.1002/1878-0261.13183
By:
- Khalil, Md Imtiaz;
- Singh, Vibha;
- King, Judy;
- De Benedetti, Arrigo
Publication type:
Article
FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer.
Published in:
Molecular Oncology, 2022, v. 16, n. 13, p. 2496, doi. 10.1002/1878-0261.13166
By:
- Flodbring Larsson, Per;
- Karlsson, Richard;
- Sarwar, Martuza;
- Miftakhova, Regina;
- Tianyan Wang;
- Syed Khaja, Azharuddin Sajid;
- Semenas, Julius;
- Sa Chen;
- Hedblom, Andreas;
- Ali, Amjad;
- Ekström-Holka, Kristina;
- Simoulis, Athanasios;
- Kumar, Anjani;
- Gjörloff Wingren, Anette;
- Robinson, Brian;
- Sun Nyunt Wai;
- Mongan, Nigel P.;
- Heery, David M.;
- ÖOhlund, Daniel;
- Grundströom, Thomas
Publication type:
Article
Androgen receptor-mediated transcriptional repression targets cell plasticity in prostate cancer.
Published in:
Molecular Oncology, 2022, v. 16, n. 13, p. 2518, doi. 10.1002/1878-0261.13164
By:
- Erdmann, Éva;
- Ould Madi Berthélémy, Pauline;
- Cottard, Félicie;
- Zoe Angel, Charlotte;
- Schreyer, Edwige;
- Tao Ye;
- Morlet, Bastien;
- Negroni, Luc;
- Kieffer, Bruno;
- Céeraline, Jocelyn
Publication type:
Article
Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity.
Published in:
Molecular Oncology, 2022, v. 16, n. 13, p. 2451, doi. 10.1002/1878-0261.13140
By:
- Ying Z. Mazzu;
- YuRou Liao;
- Nandakumar, Subhiksha;
- Sjöström, Martin;
- Jehane, Lina E.;
- Ghale, Romina;
- Govindarajan, Barani;
- Gerke, Travis A.;
- Gwo-Shu Mary Lee;
- Jian-Hua Luo;
- Chinni, Sreenivasa R.;
- Mucci, Lorelei A.;
- Feng, Felix Y.;
- Kantoff, Philip W.
Publication type:
Article